Variant report
Variant | esv3332886 |
---|---|
Chromosome Location | chr5:45278195-45281193 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367667459 | chr5:45278208-45278209 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187441599 | chr5:45278209-45278210 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371843814 | chr5:45278223-45278224 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1501363 | chr5:45278253-45278254 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs368152721 | chr5:45278278-45278279 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138963034 | chr5:45278321-45278322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555478300 | chr5:45278329-45278330 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs141339144 | chr5:45278353-45278354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs552835339 | chr5:45278451-45278452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570908361 | chr5:45278469-45278470 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs541180979 | chr5:45278478-45278479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549205429 | chr5:45278500-45278501 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs538275682 | chr5:45278564-45278565 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34497944 | chr5:45278585-45278586 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72759956 | chr5:45278652-45278653 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs578129514 | chr5:45278691-45278692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112850970 | chr5:45278728-45278729 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562666933 | chr5:45278758-45278759 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575186309 | chr5:45278771-45278772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs139255478 | chr5:45278785-45278786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191937139 | chr5:45278853-45278854 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs368602775 | chr5:45278892-45278893 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149552344 | chr5:45278924-45278925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146096900 | chr5:45278960-45278961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570245856 | chr5:45279006-45279007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184813160 | chr5:45279013-45279014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188683518 | chr5:45279014-45279015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs34406589 | chr5:45279120-45279121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550008470 | chr5:45279137-45279138 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs569865256 | chr5:45279181-45279182 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369643231 | chr5:45279209-45279210 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536011516 | chr5:45279216-45279217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535752240 | chr5:45279239-45279240 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555989154 | chr5:45279240-45279241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192805379 | chr5:45279247-45279248 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140063066 | chr5:45279252-45279253 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143831232 | chr5:45279276-45279277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1032738 | chr5:45279278-45279279 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543932617 | chr5:45279294-45279295 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543610079 | chr5:45279370-45279371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576264020 | chr5:45279450-45279451 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs541775077 | chr5:45279465-45279466 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs111494482 | chr5:45279477-45279478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372674971 | chr5:45279478-45279479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375925790 | chr5:45279490-45279491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527575573 | chr5:45279546-45279547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142975135 | chr5:45279574-45279575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs540253269 | chr5:45279608-45279609 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs151104782 | chr5:45279650-45279651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113103933 | chr5:45279658-45279659 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 17133270 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Intellectual disability | 21811512 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:45277400-45280400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr5:45277800-45278200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr5:45277800-45278200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr5:45277800-45279800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr5:45277800-45279800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr5:45278000-45279000 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr5:45278000-45279800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr5:45278200-45278400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr5:45278200-45278400 | Enhancers | H1 Cell Line | embryonic stem cell |
10 | chr5:45278200-45279600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr5:45278400-45280400 | Weak transcription | H1 Cell Line | embryonic stem cell |
12 | chr5:45278400-45280600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
13 | chr5:45279000-45279600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr5:45279000-45279600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
15 | chr5:45279800-45280400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
16 | chr5:45280000-45280600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr5:45280200-45280400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
18 | chr5:45280400-45280800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
19 | chr5:45280400-45281400 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
20 | chr5:45280400-45281400 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
21 | chr5:45280600-45280800 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
22 | chr5:45280600-45280800 | ZNF genes & repeats | HUES6 Cell Line | embryonic stem cell |